Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-16 Sale | 2024-01-18 4:45 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 1,597 | $59.02 | $94,255 | 117,028 (Direct) | View |
| 2024-01-08 Sale | 2024-01-09 5:54 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,090 | $58.92 | $123,143 | 118,625 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 5:05 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,220 | $56.67 | $125,807 | 103,694 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 09:45 am | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 1,566 | $42.38 | $66,366 | 47,223 (Direct) | View |
| 2023-01-09 Sale | 2023-01-10 5:00 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,088 | $45.37 | $94,733 | 48,789 (Direct) | View |
| 2022-12-21 Sale | 2022-12-21 9:20 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 3,248 | $40.41 | $131,266 | 50,877 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 8:32 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 627 | $120.48 | $75,543 | 52,797 (Direct) | View |
| 2022-01-07 Sale | 2022-01-07 8:27 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 1,964 | $135.94 | $266,984 | 24,848 (Direct) | View |
| 2021-03-19 Sale | 2021-03-22 4:42 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,369 | $176.44 | $417,978 | 56,928 (Direct) | View |
| 2021-01-07 Sale | 2021-01-08 7:46 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,078 | $216.33 | $449,525 | 19,789 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Option Award(A) | 2024-06-05 4:16 pm | N/A 2034-05-29 | Mural Oncology plc | MURA | Hickey Benjamin Director | 8,462 | $0 | 8,462 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 10:23 am | N/A 2034-05-29 | Mural Oncology plc | MURA | Hickey Benjamin Director | 8,462 | $3.35 | 8,462 (Direct) | View |
| 2024-03-10 Option Award | 2024-03-12 5:45 pm | N/A 2028-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hickey Benjamin President, RayzeBio Org. | 9,675 | $0 | 10,546 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:57 pm | N/A 2027-03-01 | BRISTOL MYERS SQUIBB CO | BMY | Hickey Benjamin President, RayzeBio Org. | 9,858 | $0 | 9,858 (Direct) | View |
Ownership | 2024-03-04 5:52 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hickey Benjamin President, RayzeBio Org. | 0 | $0 | 31,107 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 162,484 | $0 | 0 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:13 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 17,021 | $58.75 | 120,715 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 4:30 pm | N/A 2033-12-13 | Mural Oncology plc | MURA | Hickey Benjamin Director | 15,021 | $0 | 15,021 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-10 4:23 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 22,297 | $37 | 105,914 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 81,850 | $0 | 129,073 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 9:20 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 19,149 | $0 | 50,877 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 8:00 pm | N/A 2032-06-08 | Surface Oncology Inc. | SURF | Hickey Benjamin Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-18 8:32 pm | N/A 2032-01-13 | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 28,576 | $0 | 52,797 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 6:00 pm | N/A 2032-01-03 | Surface Oncology Inc. | SURF | Hickey Benjamin Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-03-19 Exercise | 2021-03-22 4:42 pm | N/A 2030-01-05 | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,369 | $0 | 56,928 (Direct) | View |
| 2021-03-19 Exercise | 2021-03-22 4:42 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,369 | $114.33 | 56,928 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 6:18 pm | N/A 2031-01-14 | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 18,002 | $0 | 37,791 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 9:06 pm | N/A 2030-01-05 | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 54,352 | $0 | 54,352 (Direct) | View |